Richmond Pharmacology is proud to announce its participation in TheLiver Meeting 2024, hosted by the American Association for the Study of LiverDiseases (AASLD). This event gathers leading hepatology experts to discussgroundbreaking research and advancements in liver diseases. The conference willfeature a wide range of sessions, including state-of-the-art lectures,workshops, and networking opportunities.
To connect with our team during the event, please reach out to arrange ameeting.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
%202024%20img.avif)
.svg){kind=small}
.avif)
